camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'repare therap', 'repare,(-prepare)']
$rptx [15s. delayed]: issued press release on april 18, 10:15:00: repare therapeutics presents initial clinical data from the phase 1/2 tresr and attacc trials evaluating camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time